Ampicillin
/
|
Escherichia coli
|
See: Table 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Avoparcin use |
100.00 |
|
53 |
No use |
100.00 |
|
55 |
|
Streptomycin
/
|
Escherichia coli
|
See: Table 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Avoparcin use |
100.00 |
|
53 |
No use |
100.00 |
|
55 |
|
Gentamicin
/
|
Escherichia coli
|
See: Table 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Avoparcin use |
17.00 |
|
53 |
No use |
78.00 |
|
55 |
|
Oxytetracycline
/
|
Escherichia coli
|
See: Table 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Avoparcin use |
100.00 |
|
53 |
No use |
100.00 |
|
55 |
|
Chloramphenicol
/
|
Escherichia coli
|
See: Table 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Avoparcin use |
98.00 |
|
53 |
No use |
100.00 |
|
55 |
|
Trimethoprim
/
|
Escherichia coli
|
See: Table 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Avoparcin use |
100.00 |
|
53 |
No use |
100.00 |
|
55 |
|
Sulfamethoxazole
/
|
Escherichia coli
|
See: Table 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Avoparcin use |
100.00 |
|
53 |
No use |
100.00 |
|
55 |
|
Penicillins, Combinations With Other Antibacterials
/
|
Escherichia coli
|
See: Table 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Avoparcin use |
100.00 |
|
53 |
No use |
100.00 |
|
55 |
|
Gentamicin
/
|
Enterococcus Not Specified
|
See: Table 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Avoparcin use |
25.00 |
|
53 |
No use |
7.00 |
|
55 |
|
Ampicillin
/
|
Enterococcus Not Specified
|
See: Table 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Avoparcin use |
0.00 |
|
53 |
No use |
4.00 |
|
55 |
|
Erythromycin
/
|
Enterococcus Not Specified
|
See: Table 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Avoparcin use |
100.00 |
|
53 |
No use |
100.00 |
|
55 |
|
Vancomycin
/
|
Enterococcus Not Specified
|
See: Table 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Avoparcin use |
72.00 |
|
53 |
No use |
44.00 |
|
55 |
|